Atypical small acinar proliferation: Utility of additional sections and immunohistochemical analysis of prostatic needle biopsies

Nephro-Urology Monthly

Volumn 4, Issue 2, 2012, Pages 443-447

  Arista Nasr, Julián ^a   Martínez Mijangos, Omar ^a   Martínez Benítez, Braulio ^a   Bornstein Quevedo, Leticia ^a   Lino Silva, Saul ^b   Urbina Ramírez, Shaddaí ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

Author keywords

Needle Carcinoma Neoplasm; Prostate Biopsy; Residual

Indexed keywords

CYTOKERATIN; CYTOKERATIN 34BETAE12; EOSIN; HEMATOXYLIN; KERATIN ANTIBODY; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

ACINAR CELL; ADULT; AGED; ARTICLE; ATYPICAL SMALL ACINAR CELL; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIGITAL RECTAL EXAMINATION; FOCAL PROSTATIC GLANDULAR ATYPIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MALE; NEEDLE BIOPSY; PROSTATE BIOPSY; PROSTATE CARCINOMA; PROSTATE DISEASE; TISSUE SECTION;

EID: 84858398953     PISSN: 22517006     EISSN: 22517014     Source Type: Journal    
DOI: 10.5812/numonthly.2067     Document Type: Article

References (13)

1. Cheville JC, Reznicek MJ, Bostwick DG. The focus of "atypical glands, suspicious for malignancy" in prostatic needle biopsy specimens: incidence, histologic features, and clinical follow-up of cases diagnosed in a community practice. Am J Clin Pathol. 1997;108(6):633-40.
2. Iczkowski KA, MacLennan GT, Bostwick DG. Atypical small acinar proliferation suspicious for malignancy in prostate needle biopsies: clinical significance in 33 cases. Am J Surg Pathol. 1997;21(12):1489-95.
3. Girasole CR, Cookson MS, Putzi MJ, Chang SS, Smith JA, Jr., Wells N, et al. Significance of atypical and suspicious small acinar proliferations, and high grade prostatic intraepithelial neoplasia on prostate biopsy: implications for cancer detection and biopsy strategy. J Urol. 2006;175(3 Pt 1):929-33; discussion 33.
4. Chan TY, Epstein JI. Follow-up of atypical prostate needle biopsies suspicious for cancer. Urology. 1999;53(2):351-5.
5. Iczkowski KA, Bostwick DG. Criteria for biopsy diagnosis of minimal volume prostatic adenocarcinoma: analytic comparison with nondiagnostic but suspicious atypical small acinar proliferation. Arch Pathol Lab Med. 2000;124(1):98-107.
6. Renshaw AA. Adequate tissue sampling of prostate core needle biopsies. Am J Clin Pathol. 1997;107(1):26-9.
7. Reyes AO, Humphrey PA. Diagnostic effect of complete histologic sampling of prostate needle biopsy specimens. Am J Clin Pathol. 1998;109(4):416-22.
8. Bonney WW, Robinson RA, Lachenbruch PA, Culp DA. Yield of cancer tissue from prostatic needle biopsy. Urology. 1987;29(2):153-6.
9. Arista-Nasr J, Keirns C. The focus of "atypical glands, suspicious for malignancy" in prostatic needle biopsy specimens. Am J Clin Pathol. 1998;110(3):409.
10. Arista-Nasr J, Martinez-Mijangos O, Martinez-Benitez B. [Utility of additional histological sections on prostatic needle biopsies with focal glandular atypia]. Actas Urol Esp. 2008;32(6):594-8.
11. Rodriguez-Covarrubias F, Gonzalez-Ramirez A, Aguilar-Davidov B, Castillejos-Molina R, Sotomayor M, Feria-Bernal G. Extended sampling at first biopsy improves cancer detection rate: results of a prospective, randomized trial comparing 12 versus 18-core prostate biopsy. J Urol. 2012;185(6):2132-6.
12. Chrisofos M, Papatsoris AG, Lazaris A, Deliveliotis C. Precursor lesions of prostate cancer. Crit Rev Clin Lab Sci. 2007;44(3):243-70.
13. Varma M, Linden MD, Amin MB. Effect of formalin fixation and epitope retrieval techniques on antibody 34betaE12 immunostaining of prostatic tissues. Mod Pathol. 1999;12(5):472-8.